Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Characterization of anti-phospholipid antibodies in lyme borreliosis using in-house developed ELISAs
Avtorji:ID Žigon, Polona (Avtor)
ID Lakota, Katja (Avtor)
ID Ogrinc, Katarina (Avtor)
ID Bogovič, Petra (Avtor)
ID Strle, Franc (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,35 MB)
MD5: 00EEDE7A3760D486919B563D8D4EEBF6
 
URL URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2073-4468/15/3/51
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Objectives: Borrelia burgdorferi sensu lato, a spirochete bacterium responsible for Lyme borreliosis-the most common tick-borne infection in North America and Europe-can trigger the production of antiphospholipid antibodies. These antibodies target host lipids such as cardiolipin (CL), phosphatidic acid (PA), phosphatidylcholine (PC), and phosphatidylserine (PS), which the spirochete incorporates into its membrane from the surrounding environment. Although antiphospholipid antibodies are typically associated with antiphospholipid syndrome (APS), they may also arise during infections, including Lyme borreliosis. This study aimed to develop and optimize several enzyme-linked immunosorbent assays (ELISAs) for measuring various antiphospholipid antibodies in patients with Lyme borreliosis. Methods: Thirty patients diagnosed with Lyme borreliosis were enrolled: ten with solitary erythema migrans (EM), ten with multiple EM (MEM), and ten with late manifestations known as acrodermatitis chronica atrophicans (ACA). Forty healthy blood donors served as controls. Four distinct antiphospholipid antibody ELISAs were developed, each using a different phospholipid coating: CL, PA, PC, and PS. Serum of APS patient was used as a positive control and for standard curve generation. Results: All four ELISAs were successfully established and demonstrated good measurement precision. Significant differences in antiphospholipid antibody levels and positivity rates were observed between Lyme borreliosis patients and healthy blood donors. Notably, levels of antibodies directed against PA (aPA), PC (aPC), and PS (aPS), both IgG and IgM, were significantly higher in patients with late Lyme borreliosis, manifested as ACA, compared to healthy blood donors. In contrast, anti-CL (aCL) levels did not differ significantly between groups. Patients with ACA also showed the highest frequency of multiple antiphospholipid antibody positivity, with 7 out of 10 patients testing positive for three or more antiphospholipid antibodies. Conclusions: Accurate and precise in-house ELISAs for the detection of aCL, aPA, aPC, and aPS using APS sera as standard material were developed and validated for the analysis of samples of patients with Lyme borreliosis. Our data suggest that antiphospholipid antibody levels-specifically aPA, aPC, and aPS-differ across clinical manifestations of Lyme borreliosis, with the greatest increases observed in patients with ACA.
Ključne besede:Borrelia burgdorferi sensu lato, lyme borreliosis, anti-phosphatidic acid antibodies, anti-phosphatidylcholine antibodies, anti-phosphatidylserine antibodies, antiphospholipid antibodies
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:str. 1-12
Številčenje:Vol. 15, iss. 3 [article no.] 51
PID:20.500.12556/DiRROS-31232 Novo okno
UDK:616.98:579.834.1
ISSN pri članku:2073-4468
DOI:10.3390/antib15030051 Novo okno
COBISS.SI-ID:285158915 Novo okno
Opomba: Nasl. z nasl. zaslona; Opis vira z dne 17. 7. 2026;
Datum objave v DiRROS:22.07.2026
Število ogledov:214
Število prenosov:144
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Antibodies
Skrajšan naslov:Antibodies
Založnik:MDPI
ISSN:2073-4468
COBISS.SI-ID:3289339 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0296-2022
Naslov:Bolezni in povzročitelji, ki jih v Sloveniji prenašajo členonožci

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0314-2022
Naslov:Sistemske avtoimunske bolezni

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Univerzitetni klinični center Ljubljana
Številka projekta:20250109
Naslov:Antifosfolipidna protitelesa pri odraslih bolnikih z različnimi oblikami lymske borelioze

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:lajmska borelioza, protitelesa proti fosfatidni kislini, protitelesa proti fosfatidilholinu, protitelesa proti fosfatidilserinu, antifosfolipidna protitelesa


Nazaj